Bougie or Stylet In Patients Undergoing Intubation Emergently (BOUGIE)

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03928925
Collaborator
(none)
1,106
11
2
22.5
100.5
4.5

Study Details

Study Description

Brief Summary

Complications are common during tracheal intubations performed outside of the operating room. Successful intubation on the first attempt has been associated with a lower rate of procedural complications, but the proportion of critically ill patients intubated on the first attempt during tracheal intubations outside of the operating room is less than 90%. The bougie, a thin semi-rigid tube that can be placed into the trachea, allowing a Seldinger-like technique of intubating a patient's airway, has been traditionally reserved for difficult or failed airways. However, a recent single center trial of adult patients intubated in an emergency department demonstrated that use of the bougie on the first attempt improved intubation success, compared to use of a traditional stylet.

Theinvestigators propose a multi-center randomized trial to compare first-attempt bougie use versus endotracheal tube with stylet use for tracheal intubation of critically ill adults in the ED and ICU.

Condition or Disease Intervention/Treatment Phase
  • Other: Bougie
  • Other: Endotracheal Tube with Stylet
N/A

Detailed Description

The BOUGIE trial is a prospective, parallel group, pragmatic, randomized trial comparing the effect of bougie use versus endotracheal tube with stylet use on the incidence of successful intubation on the first attempt among adults undergoing urgent or emergent tracheal intubation.

Patients admitted to the study units who are deemed by their clinical team to require intubation and fulfill inclusion criteria without meeting exclusion criteria will be randomized 1:1 to use of a bougie or use of an endotracheal tube and stylet on the first attempt at intubation. All other decisions regarding airway management, including the choice to use a bougie or endotracheal tube and stylet on subsequent attempts, will remain at the discretion of the treating provider.

The trial will enroll 1,106 patients. Conduct of the trial will be overseen by a Data Safety Monitoring Board. An interim analysis will be performed after the enrollment of 553 patients. The analysis of the trial will be conducted in accordance with a pre-specified statistical analysis plan, which will be submitted for publication or made publicly available prior to the conclusion of enrollment.

The primary outcome is successful intubation on the first attempt

The secondary outcome is severe hypoxemia (lowest arterial oxygen saturation between induction and two minutes following intubation of less than 80%)

Study Design

Study Type:
Interventional
Actual Enrollment :
1106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Bougie or Stylet In Patients Undergoing Intubation Emergently (BOUGIE): a Randomized, Multi-center Trial
Actual Study Start Date :
Apr 29, 2019
Actual Primary Completion Date :
Feb 14, 2021
Actual Study Completion Date :
Mar 13, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: BOUGIE

For patients randomized to use of a bougie, the operator will use a bougie on the first attempt at intubation. If successful, an assistant will load an endotracheal tube over the bougie, and the operator (without removing the laryngoscope from the mouth) will guide the tube through the vocal cords to the desired depth in the trachea. If the bougie is not successfully placed in the trachea or the endotracheal tube cannot be successfully advanced over the bougie on the first attempt at intubation, the operator may use any approach during subsequent attempts at tracheal intubation.

Other: Bougie
disposable tracheal tube introducer of approximately 70 cm in length

Active Comparator: Endotracheal Tube with Stylet

For patients randomized to use of an endotracheal tube with stylet, the operator will use an endotracheal tube containing a removeable, malleable stylet, on the first attempt at intubation. Manipulation of the shape/curve of the endotracheal tube with stylet is at the discretion of the operator, however a "straight-to-cuff" shape and a bend angle of 25° to 35° is encouraged. The stylet will be left in place until the tube is advanced to the trachea. If the endotracheal tube with stylet is not successfully placed in the trachea on the first attempt at intubation, the operator may use any approach during subsequent attempts at tracheal intubation.

Other: Endotracheal Tube with Stylet
endotracheal tube preloaded with a removable, malleable stylet

Outcome Measures

Primary Outcome Measures

  1. Number of intubations with successful intubation on the first attempt [from induction to 2 minutes following tracheal intubation]

    The primary outcome is successful intubation on the first attempt. Successful intubation on the first attempt is defined as placement of an endotracheal tube in the trachea (confirmed by standard means including capnography) following: (1) a single insertion of a laryngoscope blade into the mouth and (2) EITHER a single insertion of a bougie into the mouth followed by a single insertion of an endotracheal tube into the mouth OR a single insertion of an endotracheal tube with stylet into the mouth.

Secondary Outcome Measures

  1. Number of intubations with severe hypoxemia [from induction to 2 minutes following tracheal intubation]

    Defined as an oxygen saturation less than 80% during the time interval from induction to two minutes after completion of the intubation procedure

Other Outcome Measures

  1. Cormack-Lehane grade of glottic view on first attempt [from induction to 2 minutes following tracheal intubation]

    Grade 1: Full view of glottis Grade 2: Partial view of glottis Grade 3: Only epiglottis seen (none of glottis) Grade 4: Neither glottis nor epiglottis seen

  2. Number of laryngoscopy attempts [from induction to 2 minutes following tracheal intubation]

  3. Number of attempts at passing bougie [from induction to 2 minutes following tracheal intubation]

  4. Number of attempts at passing endotracheal tube [from induction to 2 minutes following tracheal intubation]

  5. Duration of intubation [from the first of induction or initiation of laryngoscopy to 2 minutes following tracheal intubation]

    The start of the procedure will be defined as either the time of first sedative administration or the time of initiation of laryngoscopy among patients who do not receive a sedative. The end of the procedure will be defined as the time of the final placement of an endotracheal tube within the trachea.

  6. Use of video laryngoscope screen [from induction to 2 minutes following tracheal intubation]

    Operator report of use of video laryngoscope screen on first attempt among intubations where the operator used a video laryngoscope

  7. Number of intubations with esophageal intubation [from induction to 2 minutes following tracheal intubation]

    Operator report of whether or not an esophageal intubation occurred

  8. Number of intubations with operator-reported aspiration [from induction to 2 minutes following tracheal intubation]

    Operator report of whether or not an an aspiration event occurred

  9. Number of intubations with airway trauma [from induction to 2 minutes following tracheal intubation]

    Operator report of whether or not airway trauma occurred

  10. Number of intubations with cardiac arrest within 1 hour following intubation [within 1 hour following intubation]

  11. Number of intubations with peri-intubation cardiovascular collapse [within 1 hour following intubation]

    Defined as any of: New systolic blood pressure < 65 mmHg between induction and 2 minutes following intubation New or increased vasopressor between induction and 2 minutes following intubation Cardiac arrest within 1 hour following intubation Death within 1 hour following intubation

  12. The number of ICU-free days, for each intubation, in the first 28 days [28 days]

  13. The number of ventilator free days, for each intubation, in the first 28 days [28 days]

  14. The number of patients who experience all-cause in-hospital mortality [28 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patient is located in a participating unit of an adult hospital

  2. Planned procedure is tracheal intubation with sedative administration (or tracheal intubation without sedative administration during cardiac arrest)

  3. Planned operator is a clinician expected to routinely perform tracheal intubation in the participating unit

  4. Planned laryngoscopy device is a non-hyperangulated laryngoscope blade

Exclusion Criteria:
  1. Patient is pregnant

  2. Patient is a prisoner

  3. Urgency of intubation precludes safe performance of study procedures

  4. Operator feels an approach to intubation other than use of a bougie or use of an endotracheal tube with stylet would be best for the care of the patient

  5. Operator feels use of a bougie is required or contraindicated for the care of the patient

  6. Operator feels use of an endotracheal tube with stylet is required or contraindicated for the care of the patient

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35233
2 University of Colorado Denver Colorado United States 80045
3 Denver Health and Hospital Authority Denver Colorado United States 80204
4 University of Iowa Hospital Iowa City Iowa United States 52242
5 Louisiana State University School of Medicine New Orleans Louisiana United States 70112
6 Ochsner Medical Center | Ochsner Health System New Orleans Louisiana United States 70112
7 Lincoln Medical Center Bronx New York United States 10451
8 Duke University Medical Center Durham North Carolina United States 27710
9 Wake Forest Baptist Health Lexington North Carolina United States 27292
10 Vanderbilt University Medical Center Nashville Tennessee United States 37209
11 Harborview Medical Center, University of Washington Seattle Washington United States 98104

Sponsors and Collaborators

  • Vanderbilt University Medical Center

Investigators

  • Study Director: Jonathan D Casey, MD, Vanderbilt University Medical Center
  • Study Chair: Matthew W Semler, MD, MSc, Vanderbilt University Medical Center
  • Principal Investigator: Brian E Driver, MD, Hennepin County Medical Center, Minneapolis
  • Principal Investigator: Matthew E Prekker, MD, Hennepin County Medical Center, Minneapolis

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jonathan Casey, Research Fellow, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT03928925
Other Study ID Numbers:
  • 182123
First Posted:
Apr 26, 2019
Last Update Posted:
Mar 22, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jonathan Casey, Research Fellow, Vanderbilt University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2021